Snapper, I., Marks, D., Schwartz, L. and Hollander, L. (1953) Hemolytic Anemia Secondary to Mesantoin. Annals of Internal Medicine, 39, 619-623.
https://doi.org/10.7326/0003-4819-39-3-619

has been cited by the following article:

• TITLE: Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease

  AUTHORS: Monica Khurana, Shekhar S. Raj

  KEYWORDS: Sickle Cell, Hemolytic Anemia, Blood Bank, Pathology

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.7 No.3, September 25, 2017

  ABSTRACT: Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin